Corbus Pharmaceuticals Holding Cash Flow-to-Debt Ratio
Corbus Pharmaceuticals Holding cash flow-to-debt ratio. Corbus Pharmaceuticals Holding (CRBP) has a Cash Flow-to-Debt Ratio of -1.20x as of June 2026, meaning its operating cash flow of $-29.63 Million could theoretically repay -1% of its total liabilities ($24.75 Million) in one year. Check earnings quality score of Corbus Pharmaceuticals Holding to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Corbus Pharmaceuticals Holding (2012–2025)
Cash flow-to-debt ratio of Corbus Pharmaceuticals Holding from 2012 to 2025. Historical debt coverage capacity for Corbus Pharmaceuticals Holding across 14 annual periods. Check CRBP total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Corbus Pharmaceuticals Holding Cash Flow-to-Debt Ratio by Year (2012–2025)
Corbus Pharmaceuticals Holding cash flow-to-debt ratio by year from 2012 to 2025. Year-by-year debt coverage analysis for Corbus Pharmaceuticals Holding. For the full cash flow conversion analysis, see Corbus Pharmaceuticals Holding (CRBP) cash conversion ratio.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.12x | $-64.49 Million | $20.69 Million | ▼ -0.3% |
| 2024 | -3.11x | $-41.79 Million | $13.45 Million | ▲ +99.7% |
| 2023 | -1026.25x | $-36.10 Billion | $35.18 Million | ▼ -90983.3% |
| 2022 | -1.13x | $-37.54 Million | $33.32 Million | ▲ +9.7% |
| 2021 | -1.25x | $-48.18 Million | $38.62 Million | ▲ +28.6% |
| 2020 | -1.75x | $-99.69 Million | $57.02 Million | ▼ -64.4% |
| 2019 | -1.06x | $-45.72 Million | $42.98 Million | ▲ +31.1% |
| 2018 | -1.54x | $-30.07 Million | $19.47 Million | ▲ +48.9% |
| 2017 | -3.02x | $-27.80 Million | $9.19 Million | ▼ -99.8% |
| 2016 | -1.51x | $-13.57 Million | $8.97 Million | ▼ -26.7% |
| 2015 | -1.19x | $-4.65 Million | $3.89 Million | ▲ +62.7% |
| 2014 | -3.20x | $-2.36 Million | $738.04K | ▼ -1722.3% |
| 2013 | -0.18x | $-366.71K | $2.09 Million | ▲ +83.0% |
| 2012 | -1.04x | $-769.73 | $743.36 | — |